Abstract
Background/Objectives:
Low serum 25-hydroxyvitamin D (25(OH)D) concentrations are related to increased mortality. One possible explanation could be an association between serum 25(OH)D and serum lipids.
Subjects/Methods:
The study was performed at the University of Tromsø, Northern Norway. In total, 8018 nonsmoking and 2087 smoking subjects were included in a cross-sectional study performed in 2008, and 1762 nonsmoking and 397 smoking subjects in a longitudinal study from 1994/1995 to 2008. Nonfasting serum 25(OH)D, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), LDL-C/HDL-C ratio and triacylglycerol (TAG) were measured.
Results:
After adjustment for gender, age, sample month and body mass index in the cross-sectional study, there was a significant increase in serum TC, HDL-C and LDL-C, and a significant decrease in serum LDL-C/HDL-C ratio and TAG across increasing serum 25(OH)D quartiles. For serum HDL-C and TAG in nonsmokers the differences between the means for the highest and lowest serum 25(OH)D quartiles were 6.0 and 18.5%, respectively. In the longitudinal study, an increase in serum 25(OH)D was associated with a significant decrease in serum TAG.
Conclusions:
There is a cross-sectional association between serum 25(OH)D and serum lipids, and a longitudinal association over 14 years between serum 25(OH)D and TAG, which may contribute to explain the relation between low serum 25(OH)D concentrations and mortality.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andersen R, Brot C, Mejborn H, Mølgaard C, Skovgaard LT, Trolle E et al. (2009). Vitamin D supplementation does not affect serum lipids and lipoproteins in Pakistani immigrants. Eur J Clin Nutr 63, 1150–1153.
Autier P, Gandini S (2007). Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 167, 1730–1737.
Auwerx J, Bouillon R, Kesteloot H (1992). Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arterioscler Thromb 12, 671–674.
Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM (2007). Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298, 309–316.
Chiu KC, Chu A, Go VL, Saad MF (2004). Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79, 820–825.
DeLuca HF (2004). Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80, 1689S–1696S.
Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B et al. (2008). Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with all-cause and cardiovascular mortality. Arch Intern Med 168, 1340–1349.
Fernandez ML, Densie Webb D (2008). The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk. J Am Coll Nutr 27, 1–5.
Ford ES, Ajani UA, McGuire LC, Liu S (2005). Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 28, 1228–1230.
Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ (2008). Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000. Diabetes 57, 2619–2625.
Gannagé-Yared MH, Chedid R, Khalife S, Azzi E, Zoghbi F, Halaby G (2009). Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol 160, 965–971.
Grimnes G, Almås B, Eggen AE, Emaus N, Figenschau Y, Hopstock L et al. (2010). Effect of smoking on the serum concentrations of 25-hydroxyvitamin D depends on the assay employed. Eur J Endocrinol 163, 339–348.
Heikkinen AM, Tuppurainen MT, Niskanen L, Komulainen M, Penttilä I, Saarikoski S (1997). Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol 137, 495–502.
Hyppönen E, Boucher BJ, Berry DJ, Power C (2008). 25-Hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 57, 298–305.
John WG, Noonan K, Mannan N, Boucher BJ (2005). Hypovitaminosis D is associated with reductions in serum apolipoprotein A-I but not with fasting lipids in British Bangladeshis. Am J Clin Nutr 82, 517–522.
Jorde R, Bonaa KH (2000). Calcium from dairy products, vitamin D intake, and blood pressure: the Tromsø Study. Am J Clin Nutr 71, 1530–1535.
Jorde R, Sneve M, Torjesen P, Figenschau Y (2009). No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D for 1 year. J Intern Med 267, 462–472.
Kannel WB, Castelli WP, Gordon T, McNamara PM (1971). Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 74, 1–12.
Lee DM, Rutter MK, O’Neill TW, Boonen S, Vanderschueren D, Bouillon R et al. (2009). European Male Ageing Study Group. Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur J Endocrinol 161, 947–954.
Leino A, Turpeinen U, Koskinen P (2008). Automated measurement of 25-OH vitamin D3 on the Roche Modular E170 analyzer. Clin Chem 54, 2059–2062.
Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R et al. (2007). Prevalence of cardiovascular risk factors and the serum concentrations of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167, 1159–1165.
Melamed ML, Michos ED, Post W, Astor B (2008). 25-Hydroxyvitamin D concentrations and the risk of mortality in the general population. Arch Intern Med 168, 1629–1637.
Miller NE, Thelle DS, Forde OH, Mjos OD (1977). The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case–control study. Lancet 1, 965–968.
Need AG, O’Loughlin PD, Horowitz M, Nordin BE (2005). Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol 62, 738–741.
Pilz S, Dobnig H, Nijpels G, Heine RJ, Stehouwer CD, Snijder MB et al. (2009). Vitamin D and mortality in older men and women. Clin Endocrinol 71, 666–672.
Reid IR (2004). Effects of calcium supplementation on circulating lipids: potential pharmacoeconomic implications. Drugs Aging 21, 7–17.
Roth HJ, Schmidt-Gayk H, Weber H, Niederau C (2008). Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Biochem 45 (Part 2), 153–159.
Schwartz JB (2009). Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence. Clin Pharmacol Ther 85, 198–203.
Scragg R, Sowers M, Bell C (2007). Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 20, 713–719.
Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM et al. (2005). Adiposity in relation to vitamin D status and parathyroid hormone concentrations: a population-based study in older men and women. J Clin Endocrinol Metab 90, 4119–4123.
Thelle DS, Førde OH, Try K, Lehmann EH (1976). The Tromsø heart study. Methods and main results of the cross-sectional study. Acta Med Scand 200, 107–118.
Wagner D, Hanwell HE, Vieth R (2009). An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem 42, 1549–1556.
Witham MD, Nadir MA, Struthers AD (2009). Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 27, 1948–1954.
Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC (2000). Regulation of adiposity by dietary calcium. FASEB J 14, 1132–1138.
Zittermann A, Frisch S, Berthold HK, Götting C, Kuhn J, Kleesiek K et al. (2009). Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89, 1321–1327.
Acknowledgements
We acknowledge the assistance by Inger Myrnes, Astrid Lindvall and Ole Martin Ryen Sand at the Department of Medical Biochemistry, University Hospital of North Norway. This study was supported by a grant from the Northern Norway Regional Health Authority.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Jorde, R., Figenschau, Y., Hutchinson, M. et al. High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. Eur J Clin Nutr 64, 1457–1464 (2010). https://doi.org/10.1038/ejcn.2010.176
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2010.176
Keywords
This article is cited by
-
Association between vitamin D deficiency and lipid profiles in overweight and obese adults: a systematic review and meta-analysis
BMC Public Health (2023)
-
Association of changes in lipid levels with changes in vitamin D levels in a real-world setting
Scientific Reports (2021)
-
Association between standardized vitamin 25(OH)D and dyslipidemia: a community-based study in Riyadh, Saudi Arabia
Environmental Health and Preventive Medicine (2020)
-
Prevalence of vitamin D deficiency and associated comorbidities among Abu Dhabi Emirates population
BMC Research Notes (2019)
-
Vitamin D Receptor Polymorphism and DHCR7 Contribute to the Abnormal Interplay Between Vitamin D and Lipid Profile in Rheumatoid Arthritis
Scientific Reports (2019)